Talis Biomedical Corp (TLIS)
9.00
-0.14
(-1.53%)
USD |
NASDAQ |
May 24, 15:38
Talis Biomedical Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2022
--
Maximum
Mar 2022
--
Average
--
Median
Mar 2022
Debt to Equity Ratio Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 0.0147 |
Xtant Medical Holdings Inc | 0.5683 |
Asensus Surgical Inc | 0.00 |
Catheter Precision Inc | 0.004 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 82.49M |
Total Liabilities (Quarterly) | 25.81M |
Shareholders Equity (Quarterly) | 56.68M |
Current Ratio | 7.514 |